Your browser doesn't support javascript.
loading
Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.
Tan, Wei Shen; Panchal, Anesh; Buckley, Laura; Devall, Adam J; Loubière, Laurence S; Pope, Ann M; Feneley, Mark R; Cresswell, Jo; Issa, Rami; Mostafid, Hugh; Madaan, Sanjeev; Bhatt, Rupesh; McGrath, John; Sangar, Vijay; Griffiths, T R Leyshon; Page, Toby; Hodgson, Dominic; Datta, Shibendra N; Billingham, Lucinda J; Kelly, John D.
Afiliação
  • Tan WS; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital, London, UK.
  • Panchal A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Buckley L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Devall AJ; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Loubière LS; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Pope AM; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Feneley MR; Department of Urology, University College London Hospital, London, UK.
  • Cresswell J; Department of Urology, James Cook University Hospital, Middlesbrough, UK.
  • Issa R; Department of Urology, St George's Hospital, London, UK.
  • Mostafid H; Department of Urology, Royal Surrey County Hospital, Guildford, UK.
  • Madaan S; Department of Urology, Darent Valley Hospital, Dartford, UK.
  • Bhatt R; Department of Urology, Queen Elizabeth Hospital, Birmingham, UK.
  • McGrath J; Department of Urology, Royal Devon and Exeter Hospital, Exeter, UK.
  • Sangar V; Department of Urology, Withington Hospital, Manchester, UK.
  • Griffiths TRL; Department of Urology, Leicester General Hospital, Leicester, UK.
  • Page T; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
  • Hodgson D; Department of Urology, Queen Alexandra Hospital, Portsmouth, UK.
  • Datta SN; Department of Urology, University Hospital of Wales, Cardiff, UK.
  • Billingham LJ; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Kelly JD; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital, London, UK. Electronic address: j.d.kelly@ucl.ac.uk.
Eur Urol ; 75(1): 63-71, 2019 01.
Article em En | MEDLINE | ID: mdl-30274699
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Vacina BCG / Mitomicina / Terapia por Radiofrequência / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Vacina BCG / Mitomicina / Terapia por Radiofrequência / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido